Antithrombin Agents as Adjuncts to Thrombolytic Therapy John K. FrenchHarvey D. White OriginalPaper Pages: 159 - 166
Pathogenesis and Pathology of Coronary Heart Disease Syndromes Paul M. RidkerElliott M. Antman OriginalPaper Pages: 167 - 189
Coronary Artery Disease and Endothelial Nitric Oxide Synthase and Angiotensin-Converting Enzyme Gene Polymorphisms Hironori NakagamiUichi IkedaKazuyuki Shimada OriginalPaper Pages: 191 - 195
Recombinant von Willebrand factor: Potential Therapeutic Use Bernhard E. Fischer OriginalPaper Pages: 197 - 205
Serum Homocysteine, MTHFR Gene Polymorphism, and Carotid Intimal-Medial Thickness in NIDDM Subjects Alfredo MazzaCorradino MottiClaudio Cortese OriginalPaper Pages: 207 - 212
Pharmacokinetics and Hemostatic Effects of Saruplase in Patients with Acute Myocardial Infarction: Comparison of Infusion, Single-Bolus, and Split-Bolus Administration H.R. MichelsJ.J.M.L. HoffmanF.W.H.M. Bär OriginalPaper Pages: 213 - 221
Randomized Clinical Trial of Urokinase versus Heparin in Unstable Angina Ji-Lin Chen OriginalPaper Pages: 223 - 226
Thrombotic Reactant Markers in Non-ST Segment Elevation Acute Coronary Syndromes Treated with Either Enoxaparin (Low Molecular Weight Heparin) or Unfractionated Heparin Enrique GurfinkelErnesto DurontoBranco Mautner OriginalPaper Pages: 227 - 232